Group One Trading’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $63.3K | Buy |
21,900
+16,600
| +313% | +$35.4K | ﹤0.01% | 5085 |
|
|
2025
Q4 | $8.53K | Buy |
5,300
+3,800
| +253% | +$5.97K | ﹤0.01% | 6896 |
|
|
2025
Q3 | $2.52K | Buy |
1,500
+900
| +150% | +$1.46K | ﹤0.01% | 7833 |
|
|
2025
Q2 | $726 | Sell |
600
-3,500
| -85% | -$5.08K | ﹤0.01% | 7615 |
|
|
2025
Q1 | $5.21K | Sell |
4,100
-700
| -15% | -$1.83K | ﹤0.01% | 6621 |
|
|
2024
Q4 | $15.6K | Sell |
4,800
-54,400
| -92% | -$196K | ﹤0.01% | 5851 |
|
|
2024
Q3 | $195K | Buy |
59,200
+29,600
| +100% | +$115K | ﹤0.01% | 3635 |
|
|
2024
Q2 | $126K | Buy |
29,600
+10,000
| +51% | +$97.4K | ﹤0.01% | 3778 |
|
|
2024
Q1 | $289K | Buy |
19,600
+16,900
| +626% | +$255K | ﹤0.01% | 3244 |
|
|
2023
Q4 | $26K | Buy |
+2,700
| New | +$18.7K | ﹤0.01% | 5550 |
|
|
2023
Q3 | – | Sell |
-100
| Closed | -$535 | – | 8026 |
|
|
2023
Q2 | $535 | Sell |
100
-7,100
| -99% | -$43.8K | ﹤0.01% | 7357 |
|
|
2023
Q1 | $51.6K | Sell |
7,200
-40,800
| -85% | -$246K | ﹤0.01% | 4822 |
|
|
2022
Q4 | $322K | Buy |
48,000
+47,500
| +9,500% | +$260K | ﹤0.01% | 3439 |
|
|
2022
Q3 | $2K | Buy |
500
+200
| +67% | +$765 | ﹤0.01% | 7167 |
|
|
2022
Q2 | $1K | Sell |
300
-20,000
| -99% | -$105K | ﹤0.01% | 7580 |
|
|
2022
Q1 | $179K | Hold |
20,300
| – | – | ﹤0.01% | 4909 |
|
|
2021
Q4 | $326K | Buy |
20,300
+19,400
| +2,156% | +$365K | ﹤0.01% | 4587 |
|
|
2021
Q3 | $19K | Sell |
900
-1,000
| -53% | -$24.1K | ﹤0.01% | 7208 |
|
|
2021
Q2 | $51K | Sell |
1,900
-2,600
| -58% | -$76.1K | ﹤0.01% | 6566 |
|
|
2021
Q1 | $143K | Sell |
4,500
-11,300
| -72% | -$274K | ﹤0.01% | 5326 |
|
|
2020
Q4 | $361K | Buy |
15,800
+15,100
| +2,157% | +$348K | ﹤0.01% | 3561 |
|
|
2020
Q3 | $18K | Sell |
700
-19,300
| -97% | -$527K | ﹤0.01% | 5179 |
|
|
2020
Q2 | $558K | Sell |
20,000
-100
| -0.5% | -$1.74K | ﹤0.01% | 2542 |
|
|
2020
Q1 | $117K | Sell |
20,100
-15,000
| -43% | -$136K | ﹤0.01% | 3174 |
|
|
2019
Q4 | $382K | Sell |
35,100
-300
| -0.8% | -$2.97K | ﹤0.01% | 2655 |
|
|
2019
Q3 | $452K | Buy |
35,400
+15,300
| +76% | +$220K | ﹤0.01% | 2414 |
|
|
2019
Q2 | $341K | Sell |
20,100
-11,400
| -36% | -$196K | ﹤0.01% | 2478 |
|
|
2019
Q1 | $566K | Buy |
31,500
+30,200
| +2,323% | +$522K | 0.01% | 1851 |
|
|
2018
Q4 | $17K | Buy |
+1,300
| New | +$21.8K | ﹤0.01% | 4089 |
|
|
2018
Q3 | – | Sell |
-800
| Closed | -$17K | – | 5443 |
|
|
2018
Q2 | $17K | Sell |
800
-900
| -53% | -$20.3K | ﹤0.01% | 4434 |
|
|
2018
Q1 | $43K | Buy |
1,700
+1,400
| +467% | +$34K | ﹤0.01% | 3736 |
|
|
2017
Q4 | $6K | Sell |
300
-4,300
| -93% | -$80.3K | ﹤0.01% | 4521 |
|
|
2017
Q3 | $85K | Sell |
4,600
-1,000
| -18% | -$17.3K | ﹤0.01% | 3335 |
|
|
2017
Q2 | $98K | Buy |
+5,600
| New | +$107K | ﹤0.01% | 3117 |
|
|
2015
Q4 | – | Sell |
-5,000
| Closed | -$107K | – | 4934 |
|
|
2015
Q3 | $107K | Sell |
5,000
-2,500
| -33% | -$78.4K | ﹤0.01% | 2989 |
|
|
2015
Q2 | $285K | Buy |
7,500
+4,900
| +188% | +$161K | ﹤0.01% | 2267 |
|
|
2015
Q1 | $82K | Buy |
2,600
+2,500
| +2,500% | +$84.7K | ﹤0.01% | 3021 |
|
|
2014
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 4544 |
|
|
2014
Q3 | $2K | Buy |
+100
| New | +$2.07K | ﹤0.01% | 4929 |
|
Other funds holding MGNX
AC
VCM
RCM
WA
Group One Trading's MGNX Position: Q3 2025 in Review
Group One Trading sold out of MacroGenics (MGNX) in Q3 2025, closing a stake of 7,509 shares — an estimated $12.2K sold.
Group One Trading first reported a position in MGNX in Q4 2014 and held it in 28 quarters. The position peaked at $523K in Q1 2019. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.
- Group One Trading reported no remaining MacroGenics position as of Q3 2025 after selling out during the quarter.
- Group One Trading sold 7,509 MacroGenics shares in Q3 2025, an estimated $12.2K.
- Group One Trading first reported a position in MacroGenics in Q4 2014 and held it in 28 quarters.
- Group One Trading's MacroGenics position peaked at $523K in Q1 2019.
- 104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.
Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.